Hippocampus and amygdalar volumes in patients with refractory obsessive-compulsive disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 5, 2008, Pages 1283-1286

  Atmaca, Murad ^a   Yildirim, Hanefi ^a   Ozdemir, Huseyin ^a   Ozler, Sinan ^a   Kara, Bilge ^a   Ozler, Zuhal ^a   Kanmaz, Ebru ^a   Mermi, Osman ^a   Tezcan, Ertan ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b MALTEPE UNIVERSITY   (Turkey)

Author keywords

Amygdala; Hippocampus; MRI; Volumetric

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY;

ADULT; AMYGDALA; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBSESSIVE-COMPULSIVE DISORDER;

EID: 49849094880     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.04.002     Document Type: Article

References (30)

1. Adler C.M., McDonough-Ryan P., Sax K.W., Holland S.K., Arndt S., and Strakowski S.M. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. J Psychiatr Res 34 (2000) 317-324
2. Atmaca M., Kuloglu K., Tezcan E., and Gecici O. Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study. Int Clin Psychopharmacol 17 (2002) 115-119
3. Barbas H., and Blatt G.J. Topographically specific hippocampal projections target functionally distinct prefrontal areas in the rhesus monkey. Hippocampus 5 (1995) 511-533
4. Bertolino A., Nawroz S., Mattay V.S., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 153 (1996) 1554-1563
5. Brambilla P., Harenski K., Nicoletti M., Sassi R.B., Mallinger A.G., Frank E., et al. MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res 37 (2003) 287-295
6. Caetano S.C., Hatch J.P., Brambilla P., Sassi R.B., Nicoletti M., Mallinger A.G., et al. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res 132 (2004) 141-147
7. Cavada C., Company T., Tejedor J., Cruz-Rizzolo R.J., and Reinoso-Suarez F. The anatomical connections of the macaque monkey orbitofrontal cortex. A review. Cereb Cortex 10 (2000) 220-242
8. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol (1993) 873-880
9. Çorapcýo{eth}lu A., Aydemir Ö., Yýldýz M., Esen A., and Köro{eth}lu E. DSM-IV Eksen I Bozukluklari{dotless} (SCID-I) İçin Yapi{dotless}landi{dotless}ri{dotless}lmi{dotless}ş Klinik Görüşme, Klinik Versiyon (1999), Hekimler Yayi{dotless}n Birliǧi, Ankara
10. Duvernoy H.M., and Cabanis E.A. The human brain: surface, three-dimensional sectional anatomy, and MRI (1991), Springer-Verlag, New York
11. Gonzalez L.E., Andrews N., and File S.E. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res 732 (1996) 145-153
12. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., et al. The Yale-Brown Obsessive Compulsive Scale II. Validity. Arch Gen Psychiatry 46 (1989) 1012-1016
13. Goodman W.K., Price L.H., Rasmussen S.A., Delgado P.L., Heninger G.R., and Charney D. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 46 (1989) 36-43
14. Gray J.A. The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system (1982), Oxford University Press, Oxford, England
15. Graybiel A.M., and Rauch S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron 28 (2000) 343-347
16. Hong S.B., Shin Y.W., Kim S.H., Yoo S.Y., Lee J.M., Kim I.Y., et al. Hippocampal shape deformity analysis in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 257 (2007) 185-190
17. Jenike M.A., Breiter H.C., Baer L., Kennedy D.N., Savage C.R., Olivares M.J., et al. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 53 (1996) 625-632
18. Kwon J.S., Shin Y.W., Kim C.W., Kim Y.I., Youn T., Han M.H., et al. Similarity and disparity of obsessive-compulsive disorder and schizophrenia in MR volumetric abnormalities of the hippocampus-amygdala complex. J Neurol Neurosurg Psychiatry 74 (2003) 962-964
19. Lawrence A.D., Sahakian B.J., and Robbins T.W. Cognitive functions and corticostriatal circuits: insights from Huntington's disease. Trend Cogn Sci 2 (1998) 379-388
20. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., and Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 164 (1994) 459-468
21. Nagy J., Zambo K., and Decsi L. Anti-anxiety action of diazepam after intra-amygdaloid application in the rat. Neuropharmacology 18 (1979) 573-576
22. Phillips M.L., Drevets W.C., Rauch S.L., and Lane R. Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54 (2003) 504-514
23. Pitman R.K. A cybernetic model of obsessive-compulsive psychopathology. Compr Psychiatry 28 (1987) 334-343
24. Saxena S., Brody A.L., Schwartz J.M., and Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatr, Suppl (1998) 26-37
25. Saxena S., Bota R.G., and Brody A.L. Brain-behavior relationships in obsessive-compulsive disorder. Sem Clin Neuropsychiatry 6 (2001) 82-101
26. Szeszko P.R., Robinson D., Alvir J.M., Bilder R.M., Lencz T., Ashtari M., et al. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 56 (1999) 913-919
27. Szeszko P.R., MacMillan S., McMeniman M., Lorch E., Madden R., Ivey J., et al. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology 29 (2004) 826-832
28. Talairach J., and Tournoux P. Coplanar stereotaxic atlas of the human brain (1998), Thieme Medical Publishers, New York
29. Van Laere K., Nuttin B., Gabriels L., Dupont P., Rasmussen S., Greenberg B.D., et al. Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 47 (2006) 740-747
30. Zangrossi Jr. H., Viana M.B., and Graeff F.G. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. Eur J Pharmacol 369 (1999) 267-270